{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T23:55:14Z","timestamp":1792454114253,"version":"4.5.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,7,30]],"date-time":"2022-07-30T00:00:00Z","timestamp":1659139200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,30]],"date-time":"2022-07-30T00:00:00Z","timestamp":1659139200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100008233","name":"School of Medicine, Shanghai Jiao Tong University","doi-asserted-by":"publisher","award":["YBKA201907"],"award-info":[{"award-number":["YBKA201907"]}],"id":[{"id":"10.13039\/501100008233","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81802739"],"award-info":[{"award-number":["81802739"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Exp Clin Cancer Res"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Ocular adnexal B-cell lymphoma (OABL) is a rare subtype of non-Hodgkin lymphoma. The molecular characteristics of OABL remain poorly understood. We performed an integrated study to investigate the proteotranscriptome landscape and identify novel molecular characteristics and biomarkers of OABL.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Integrated quantitative proteome and transcriptome were performed on 40 OABL 12 idiopathic orbital inflammation, 6 reactive lymphoid hyperplasia, and 13 aesthetic orbital plastic surgery specimens. Complete clinicopathologic and prognostic data of the patients were recorded.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We identified high global protein-mRNA concordance as a novel characteristic of OABL. High concordance was related to OABL recurrence. By integrated expression profile, motif enrichment and trend analysis, we found that alternative splicing is inflammation-independently dysregulated in OABL. After portraying the aberrant alternative splicing event landscape, we demonstrated the oncogenic role of ADAR, a core splicing regulator that regulates the splicing of Rho GTPase and cell cycle members. We found that ADAR regulates cell proliferation and Rho GTPase inhibitor sensitivity of lymphoma. We identified DNAJC9 as a potential biomarker for OABL in proteomic analyses. Immunohistochemistry and immunofluorescent staining showed the nuclear staining of DNAJC9 was significantly higher in extranodal marginal zone lymphomas compared with inflammation specimens.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>These results provide an integrated gene expression profiling and demonstrate that high global protein-mRNA concordance is a prognosis-related molecular characteristic of OABL. We portray the alternative splicing events landscape of OABL, and reveal the oncogenic role of ADAR. We identified strong nuclear staining of DNAJC9 as a promising pathology diagnostic biomarker for extranodal marginal zone lymphomas.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13046-022-02445-8","type":"journal-article","created":{"date-parts":[[2022,7,30]],"date-time":"2022-07-30T03:28:52Z","timestamp":1659151732000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Proteotranscriptomics of ocular adnexal B-cell lymphoma reveals an oncogenic role of alternative splicing and identifies a diagnostic marker"],"prefix":"10.1186","volume":"41","author":[{"given":"Jiahao","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianyu","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huimin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyao","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowen","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yefei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renbing","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianqun","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9976-610X","authenticated-orcid":false,"given":"Yixiong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,30]]},"reference":[{"key":"2445_CR1","first-page":"145","volume-title":"Orbital and ocular adnexal lymphoma. Orbital Tumors","author":"B Esmaeli","year":"2015","unstructured":"Esmaeli B, Sniegowski M. Orbital and ocular adnexal lymphoma. Orbital Tumors; 2015. p. 145\u201353."},{"key":"2445_CR2","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/978-3-642-40492-4_12","volume-title":"Orbital and adnexal lymphoma. Clinical ophthalmic Oncology","author":"ME Aronow","year":"2014","unstructured":"Aronow ME, Hill BT, Singh AD. Orbital and adnexal lymphoma. Clinical ophthalmic Oncology; 2014. p. 123\u201339."},{"key":"2445_CR3","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1186\/s12886-021-02108-w","volume":"21","author":"N Shimizu","year":"2021","unstructured":"Shimizu N, Oshitari T, Yotsukura J, Yokouchi H, Baba T, Yamamoto S. Ten-year epidemiological study of ocular and orbital tumors in Chiba University Hospital. BMC Ophthalmol. 2021;21:344.","journal-title":"BMC Ophthalmol"},{"key":"2445_CR4","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.ajo.2018.11.002","volume":"199","author":"TG Olsen","year":"2019","unstructured":"Olsen TG, Holm F, Mikkelsen LH, Rasmussen PK, Coupland SE, Esmaeli B, et al. Orbital lymphoma-An international multicenter retrospective study. Am J Ophthalmol. 2019;199:44\u201357.","journal-title":"Am J Ophthalmol"},{"key":"2445_CR5","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1038\/s41433-020-01198-y","volume":"35","author":"CR Hsu","year":"2021","unstructured":"Hsu CR, Chen YY, Yao M, Wei YH, Hsieh YT, Liao SL. Orbital and ocular adnexal lymphoma: a review of epidemiology and prognostic factors in Taiwan. Eye (Lond). 2021;35:1946\u201353.","journal-title":"Eye (Lond)"},{"key":"2445_CR6","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1136\/bjophthalmol-2019-315637","volume":"105","author":"F Holm","year":"2021","unstructured":"Holm F, Mikkelsen LH, Kamper P, Rasmussen PK, Larsen TS, Sjo LD, et al. Ocular adnexal lymphoma in Denmark: a nationwide study of 387 cases from 1980 to 2017. Br J Ophthalmol. 2021;105:914\u201320.","journal-title":"Br J Ophthalmol"},{"key":"2445_CR7","doi-asserted-by":"publisher","first-page":"3458","DOI":"10.3390\/jcm9113458","volume":"9","author":"M Asakage","year":"2020","unstructured":"Asakage M, Usui Y, Nezu N, Shimizu H, Tsubota K, Umazume K, et al. Comprehensive gene analysis of IgG4-related ophthalmic disease using RNA sequencing. J Clin Med. 2020;9:3458.","journal-title":"J Clin Med"},{"key":"2445_CR8","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1200\/JCO.18.01583","volume":"37","author":"D Ennishi","year":"2019","unstructured":"Ennishi D, Jiang A, Boyle M, Collinge B, Grande BM, Ben-Neriah S, et al. Double-hit gene expression signature defines a distinct subgroup of germinal center B-cell-like diffuse large B-cell lymphoma. J Clin Oncol. 2019;37:190\u2013201.","journal-title":"J Clin Oncol"},{"key":"2445_CR9","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s13073-019-0637-7","volume":"11","author":"H Loeffler-Wirth","year":"2019","unstructured":"Loeffler-Wirth H, Kreuz M, Hopp L, Arakelyan A, Haake A, Cogliatti SB, et al. A modular transcriptome map of mature B cell lymphomas. Genome Med. 2019;11:27.","journal-title":"Genome Med."},{"key":"2445_CR10","doi-asserted-by":"publisher","first-page":"3270","DOI":"10.3390\/cancers12113270","volume":"12","author":"J Dunn","year":"2020","unstructured":"Dunn J, Lenis VP, Hilton DA, Warta R, Herold-Mende C, Hanemann CO, et al. Integration and Comparison of Transcriptomic and Proteomic Data for Meningioma. Cancers (Basel). 2020;12:3270.","journal-title":"Cancers (Basel)"},{"key":"2445_CR11","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s13073-018-0602-x","volume":"10","author":"W Tang","year":"2018","unstructured":"Tang W, Zhou M, Dorsey TH, Prieto DA, Wang XW, Ruppin E, et al. Integrated proteotranscriptomics of breast cancer reveals globally increased protein-mRNA concordance associated with subtypes and survival. Genome Med. 2018;10:94.","journal-title":"Genome Med"},{"key":"2445_CR12","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.molcel.2019.09.017","volume":"76","author":"J Ule","year":"2019","unstructured":"Ule J, Blencowe BJ. Alternative splicing regulatory networks: functions, mechanisms, and evolution. Mol Cell. 2019;76:329\u201345.","journal-title":"Mol Cell"},{"key":"2445_CR13","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/s41571-020-0350-x","volume":"17","author":"SC Bonnal","year":"2020","unstructured":"Bonnal SC, Lopez-Oreja I, Valcarcel J. Roles and mechanisms of alternative splicing in cancer - implications for care. Nat Rev Clin Oncol. 2020;17:457\u201374.","journal-title":"Nat Rev Clin Oncol"},{"key":"2445_CR14","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1146\/annurev-pathol-020117-043803","volume":"13","author":"KSJ Elenitoba-Johnson","year":"2018","unstructured":"Elenitoba-Johnson KSJ, Lim MS. New insights into lymphoma pathogenesis. Annu Rev Pathol. 2018;13:193\u2013217.","journal-title":"Annu Rev Pathol"},{"key":"2445_CR15","first-page":"E5593","volume":"111","author":"S Shen","year":"2014","unstructured":"Shen S, Park JW, Lu ZX, Lin L, Henry MD, Wu YN, et al. rMATS: robust and flexible detection of differential alternative splicing from replicate RNA-Seq data. Proc Natl Acad Sci U S A. 2014;111:E5593\u2013601.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2445_CR16","doi-asserted-by":"publisher","first-page":"D125","DOI":"10.1093\/nar\/gks997","volume":"41","author":"M Giulietti","year":"2013","unstructured":"Giulietti M, Piva F, D'Antonio M, D'Onorio De Meo P, Paoletti D, Castrignano T, et al. SpliceAid-F: a database of human splicing factors and their RNA-binding sites. Nucleic Acids Res. 2013;41:D125\u201331.","journal-title":"Nucleic Acids Res"},{"key":"2445_CR17","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1038\/s41586-020-2077-3","volume":"583","author":"EL Van Nostrand","year":"2020","unstructured":"Van Nostrand EL, Freese P, Pratt GA, Wang X, Wei X, Xiao R, et al. A large-scale binding and functional map of human RNA-binding proteins. Nature. 2020;583:711\u20139.","journal-title":"Nature."},{"key":"2445_CR18","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, et al. Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43:e47.","journal-title":"Nucleic Acids Res"},{"key":"2445_CR19","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1038\/s41467-019-09234-6","volume":"10","author":"Y Zhou","year":"2019","unstructured":"Zhou Y, Zhou B, Pache L, Chang M, Khodabakhshi AH, Tanaseichuk O, et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat Commun. 2019;10:1523.","journal-title":"Nat Commun"},{"key":"2445_CR20","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/ng1180","volume":"34","author":"VK Mootha","year":"2003","unstructured":"Mootha VK, Lindgren CM, Eriksson KF, Subramanian A, Sihag S, Lehar J, et al. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet. 2003;34:267\u201373.","journal-title":"Nat Genet"},{"key":"2445_CR21","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102:15545\u201350.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2445_CR22","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S Hanzelmann","year":"2013","unstructured":"Hanzelmann S, Castelo R, Guinney J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinformatics. 2013;14:7.","journal-title":"BMC Bioinformatics"},{"key":"2445_CR23","doi-asserted-by":"publisher","first-page":"R80","DOI":"10.1186\/gb-2004-5-10-r80","volume":"5","author":"RC Gentleman","year":"2004","unstructured":"Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S, et al. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol. 2004;5:R80.","journal-title":"Genome Biol"},{"key":"2445_CR24","doi-asserted-by":"publisher","first-page":"3966","DOI":"10.1016\/j.febslet.2009.10.036","volume":"583","author":"T Maier","year":"2009","unstructured":"Maier T, Guell M, Serrano L. Correlation of mRNA and protein in complex biological samples. FEBS Lett. 2009;583:3966\u201373.","journal-title":"FEBS Lett"},{"key":"2445_CR25","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.tibs.2004.11.009","volume":"30","author":"P Viatour","year":"2005","unstructured":"Viatour P, Merville MP, Bours V, Chariot A. Phosphorylation of NF-kappaB and IkappaB proteins: implications in cancer and inflammation. Trends Biochem Sci. 2005;30:43\u201352.","journal-title":"Trends Biochem Sci"},{"key":"2445_CR26","doi-asserted-by":"publisher","first-page":"189","DOI":"10.3390\/cells7110189","volume":"7","author":"R Kennedy","year":"2018","unstructured":"Kennedy R, Klein U. Aberrant activation of NF-kappaB Signalling in aggressive lymphoid malignancies. Cells. 2018;7:189.","journal-title":"Cells."},{"key":"2445_CR27","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1093\/jnci\/djj004","volume":"98","author":"KE Smedby","year":"2006","unstructured":"Smedby KE, Hjalgrim H, Askling J, Chang ET, Gregersen H, Porwit-MacDonald A, et al. Autoimmune and chronic inflammatory disorders and risk of non-Hodgkin lymphoma by subtype. J Natl Cancer Inst. 2006;98:51\u201360.","journal-title":"J Natl Cancer Inst"},{"key":"2445_CR28","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1111\/joim.12684","volume":"282","author":"KE Smedby","year":"2017","unstructured":"Smedby KE, Ponzoni M. The aetiology of B-cell lymphoid malignancies with a focus on chronic inflammation and infections. J Intern Med. 2017;282:360\u201370.","journal-title":"J Intern Med"},{"key":"2445_CR29","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12943-016-0579-2","volume":"16","author":"D Pradella","year":"2017","unstructured":"Pradella D, Naro C, Sette C, Ghigna C. EMT and stemness: flexible processes tuned by alternative splicing in development and cancer progression. Mol Cancer. 2017;16:8.","journal-title":"Mol Cancer"},{"key":"2445_CR30","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1038\/s41467-022-28253-4","volume":"13","author":"R Siddaway","year":"2022","unstructured":"Siddaway R, Milos S, Vadivel AKA, Dobson THW, Swaminathan J, Ryall S, et al. Splicing is an alternate oncogenic pathway activation mechanism in glioma. Nat Commun. 2022;13:588.","journal-title":"Nat Commun"},{"key":"2445_CR31","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","volume":"2","author":"E Cerami","year":"2012","unstructured":"Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA, et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012;2:401\u20134.","journal-title":"Cancer Discov"},{"key":"2445_CR32","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/s41467-020-14621-5","volume":"11","author":"SJ Tang","year":"2020","unstructured":"Tang SJ, Shen H, An O, Hong H, Li J, Song Y, et al. Cis- and trans-regulations of pre-mRNA splicing by RNA editing enzymes influence cancer development. Nat Commun. 2020;11:799.","journal-title":"Nat Commun"},{"key":"2445_CR33","doi-asserted-by":"publisher","first-page":"646","DOI":"10.3390\/cells8070646","volume":"8","author":"C Voena","year":"2019","unstructured":"Voena C, Chiarle R. RHO family GTPases in the biology of lymphoma. Cells. 2019;8:646.","journal-title":"Cells."},{"key":"2445_CR34","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1152\/physrev.00045.2020","volume":"102","author":"E Crosas-Molist","year":"2022","unstructured":"Crosas-Molist E, Samain R, Kohlhammer L, Orgaz JL, George SL, Maiques O, et al. Rho GTPase signaling in cancer progression and dissemination. Physiol Rev. 2022;102:455\u2013510.","journal-title":"Physiol Rev"},{"key":"2445_CR35","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.survophthal.2018.08.002","volume":"64","author":"TG Olsen","year":"2019","unstructured":"Olsen TG, Heegaard S. Orbital lymphoma. Surv Ophthalmol. 2019;64:45\u201366.","journal-title":"Surv Ophthalmol"},{"key":"2445_CR36","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/nrc.2017.99","volume":"18","author":"E Anastasiadou","year":"2018","unstructured":"Anastasiadou E, Jacob LS, Slack FJ. Non-coding RNA networks in cancer. Nat Rev Cancer. 2018;18:5\u201318.","journal-title":"Nat Rev Cancer"},{"key":"2445_CR37","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s12943-020-01216-3","volume":"19","author":"Z Zhou","year":"2020","unstructured":"Zhou Z, Lv J, Yu H, Han J, Yang X, Feng D, et al. Mechanism of RNA modification N6-methyladenosine in human cancer. Mol Cancer. 2020;19:104.","journal-title":"Mol Cancer"},{"key":"2445_CR38","first-page":"A5206","volume":"63","author":"M Ostergaard Poulsen","year":"2016","unstructured":"Ostergaard Poulsen M, Krogh Jorgensen L, Sorensen S, Falgreen S, Stove Bodker JS, Bach Laursen M, et al. Alternative pre-mRNA splicing leads to potential biomarkers in diffuse large B-cell lymphoma - a systematic review. Dan Med J. 2016;63:A5206.","journal-title":"Dan Med J"},{"key":"2445_CR39","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/s41586-018-0768-9","volume":"565","author":"JJ Ishizuka","year":"2019","unstructured":"Ishizuka JJ, Manguso RT, Cheruiyot CK, Bi K, Panda A, Iracheta-Vellve A, et al. Loss of ADAR1 in tumours overcomes resistance to immune checkpoint blockade. Nature. 2019;565:43\u20138.","journal-title":"Nature."},{"key":"2445_CR40","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.trecan.2019.03.004","volume":"5","author":"A Herbert","year":"2019","unstructured":"Herbert A. ADAR and immune silencing in Cancer. Trends Cancer. 2019;5:272\u201382.","journal-title":"Trends Cancer"},{"key":"2445_CR41","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1007\/s11064-019-02943-w","volume":"45","author":"X Lv","year":"2020","unstructured":"Lv X, Gu C, Guo S. Activation of BDNF-AS\/ADAR\/p53 positive feedback loop inhibits glioblastoma cell proliferation. Neurochem Res. 2020;45:508\u201318.","journal-title":"Neurochem Res"},{"key":"2445_CR42","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1038\/s41588-021-00859-2","volume":"53","author":"Z Wu","year":"2021","unstructured":"Wu Z, Zhou J, Zhang X, Zhang Z, Xie Y, Liu JB, et al. Reprogramming of the esophageal squamous carcinoma epigenome by SOX2 promotes ADAR1 dependence. Nat Genet. 2021;53:881\u201394.","journal-title":"Nat Genet"},{"key":"2445_CR43","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1002\/jmri.25480","volume":"45","author":"B Sun","year":"2017","unstructured":"Sun B, Song L, Wang X, Li J, Xian J, Wang F, et al. Lymphoma and inflammation in the orbit: diagnostic performance with diffusion-weighted imaging and dynamic contrast-enhanced MRI. J Magn Reson Imaging. 2017;45:1438\u201345.","journal-title":"J Magn Reson Imaging"},{"key":"2445_CR44","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s40618-019-01141-3","volume":"43","author":"M Marino","year":"2020","unstructured":"Marino M, Ionni I, Lanzolla G, Sframeli A, Latrofa F, Rocchi R, et al. Orbital diseases mimicking graves\u2019 orbitopathy: a long-standing challenge in differential diagnosis. J Endocrinol Investig. 2020;43:401\u201311.","journal-title":"J Endocrinol Investig"},{"key":"2445_CR45","doi-asserted-by":"publisher","first-page":"153","DOI":"10.3322\/caac.21330","volume":"66","author":"M Raderer","year":"2016","unstructured":"Raderer M, Kiesewetter B, Ferreri AJ. Clinicopathologic characteristics and treatment of marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma). CA Cancer J Clin. 2016;66:153\u201371.","journal-title":"CA Cancer J Clin"},{"key":"2445_CR46","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s10238-017-0474-1","volume":"18","author":"D Kalogeropoulos","year":"2018","unstructured":"Kalogeropoulos D, Papoudou-Bai A, Kanavaros P, Kalogeropoulos C. Ocular adnexal marginal zone lymphoma of mucosa-associated lymphoid tissue. Clin Exp Med. 2018;18:151\u201363.","journal-title":"Clin Exp Med"},{"key":"2445_CR47","doi-asserted-by":"publisher","first-page":"32474","DOI":"10.1038\/srep32474","volume":"6","author":"B Mandriani","year":"2016","unstructured":"Mandriani B, Castellana S, Rinaldi C, Manzoni M, Venuto S, Rodriguez-Aznar E, et al. Identification of p53-target genes in Danio rerio. Sci Rep. 2016;6:32474.","journal-title":"Sci Rep"},{"key":"2445_CR48","doi-asserted-by":"publisher","first-page":"2533","DOI":"10.1016\/j.molcel.2021.03.041","volume":"81","author":"CM Hammond","year":"2021","unstructured":"Hammond CM, Bao H, Hendriks IA, Carraro M, Garcia-Nieto A, Liu Y, et al. DNAJC9 integrates heat shock molecular chaperones into the histone chaperone network. Mol Cell. 2021;81:2533\u201348 e9.","journal-title":"Mol Cell"}],"container-title":["Journal of Experimental &amp; Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-022-02445-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13046-022-02445-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-022-02445-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,30]],"date-time":"2022-07-30T04:03:17Z","timestamp":1659153797000},"score":1,"resource":{"primary":{"URL":"https:\/\/jeccr.biomedcentral.com\/articles\/10.1186\/s13046-022-02445-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,30]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["2445"],"URL":"https:\/\/doi.org\/10.1186\/s13046-022-02445-8","relation":{},"ISSN":["1756-9966"],"issn-type":[{"value":"1756-9966","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,30]]},"assertion":[{"value":"5 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The research followed the tenets of the Declaration of Helsinki. The collection of biospecimens and the clinical and pathological information was approved by the institutional review board of Ninth People\u2019s Hospital, Shanghai Jiao Tong University School of Medicine (approval No. SH9H-2019\u2009T185\u20132). Investigators obtained informed consent for patients enrolled in proteomic and transcriptomic analyses.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"234"}}